Hypertension: Detailed Nursing Notes + Diagrams + 25-Question MCQ Test for NORCET

HYPERTENSION — COMPLETE NURSING NOTES

Adult Health Nursing | Cardiovascular Disorders | NORCET 12

Detailed revision notes on blood pressure classification, diagnostic parameters, causes, pathophysiology, investigations, antihypertensive drugs, hypertensive emergencies, nursing management and case-based MCQs.

Guideline-Aware Clinical Parameters Diagrams Included 25 Interactive MCQs

Learning Objectives

  • Define hypertension and explain systolic and diastolic blood pressure.
  • Differentiate blood pressure categories used in major guidelines.
  • Describe primary and secondary hypertension.
  • Explain the pathophysiology and target-organ complications.
  • Identify the investigations and major classes of antihypertensive medicines.
  • Recognize hypertensive emergency and priority nursing interventions.
  • Apply hypertension knowledge to clinical scenarios.

Table of Contents

1. Definition and Basic Concepts

Hypertension is a persistent elevation of arterial blood pressure above the threshold used by the applicable clinical guideline. Diagnosis generally relies on properly measured, repeated readings and may require confirmation with home or ambulatory monitoring.

Blood pressure components

  • Systolic blood pressure (SBP): arterial pressure during ventricular contraction.
  • Diastolic blood pressure (DBP): arterial pressure during ventricular relaxation.
  • Pulse pressure (PP): difference between systolic and diastolic pressure.
  • Mean arterial pressure (MAP): approximate average arterial pressure during one cardiac cycle.
Important formulas:
Pulse Pressure = SBP − DBP
Approximate MAP = DBP + 1/3 (SBP − DBP), when heart rate and rhythm allow this approximation.

Example: For a BP of 120/80 mmHg:

  • Pulse pressure = 120 − 80 = 40 mmHg.
  • Approximate MAP = 80 + (40/3) ≈ 93 mmHg.
Exam point: A person may have hypertension without headache, dizziness or any other obvious symptom. The condition is often detected through routine measurement.

2. Latest Guideline Classification and Parameters

Blood pressure categories differ between guidelines. For examinations and clinical practice, identify which guideline is being referenced rather than combining thresholds from different systems.

A. AHA/ACC 2025 adult classification

CategorySystolic BPDiastolic BP
Normal<120 mmHgAND <80 mmHg
Elevated120–129 mmHgAND <80 mmHg
Stage 1 hypertension130–139 mmHgOR 80–89 mmHg
Stage 2 hypertension≥140 mmHgOR ≥90 mmHg

In this framework, either the systolic or diastolic value can place a reading in a higher category. Classification is based on the average of careful measurements, generally taken on more than one occasion.

B. NICE adult diagnostic thresholds

MeasurementThreshold used to confirm hypertension
Clinic BP≥140/90 mmHg, followed by confirmation with ABPM or HBPM when appropriate
Daytime ABPM average≥135/85 mmHg
Home BP average≥135/85 mmHg

Under NICE guidance, clinic readings of 140/90 mmHg or higher are generally followed by ambulatory blood pressure monitoring (ABPM), or home blood pressure monitoring (HBPM) if ABPM is unsuitable. Diagnosis depends on the clinical context and confirmatory measurements.

C. Practical comparison for nursing exams

Clinical or examination contextKey parameter
AHA/ACC 2025 Stage 1130–139 systolic OR 80–89 diastolic
AHA/ACC 2025 Stage 2≥140 systolic OR ≥90 diastolic
NICE clinic diagnosis threshold≥140/90 mmHg, with confirmation as appropriate
NICE home/daytime ABPM thresholdAverage ≥135/85 mmHg
Severely elevated BP requiring prompt assessmentApproximately ≥180 systolic and/or ≥120 diastolic is an important warning threshold; symptoms and acute organ injury determine urgency
Critical distinction: A blood pressure around or above 180/120 mmHg is not, by itself, enough to define a hypertensive emergency. A hypertensive emergency involves severe BP elevation with acute target-organ damage. However, a very high reading requires prompt reassessment and clinical evaluation; do not ignore it just because symptoms are absent.

D. Treatment targets: why they vary

  • The AHA/ACC framework generally uses a treatment goal below 130/80 mmHg for many adults receiving treatment, when appropriate and tolerated.
  • NICE uses different clinic and home/ambulatory targets based on age and clinical context. For many adults under 80, its general clinic target is below 140/90 mmHg and its home/daytime ABPM target is below 135/85 mmHg.
  • Targets may be individualized in older adults, frailty, orthostatic hypotension, chronic kidney disease, diabetes, cardiovascular disease and pregnancy.
Guideline update note: The 2025 AHA/ACC guideline emphasizes accurate measurement, cardiovascular-risk assessment, lifestyle intervention, home BP monitoring and appropriate use of combination therapy. Do not apply an adult non-pregnant BP table to pregnancy or paediatric patients.

3. Correct Blood Pressure Measurement

Before measuring

  1. Ask the patient to avoid smoking, caffeine and exercise for at least 30 minutes beforehand when feasible.
  2. Ask the patient to empty their bladder if needed.
  3. Allow at least 5 minutes of quiet rest.
  4. Seat the patient with back supported, feet flat on the floor and legs uncrossed.
  5. Use a validated upper-arm device and the correct cuff size.
  6. Place the cuff on a bare arm supported at heart level.
  7. Do not talk during rest or measurement.
  8. Take repeat readings and interpret the average according to the relevant protocol.
Correct BP measurement position Cuff on bare upper arm Arm supported at heart level Back supported Feet flat, legs uncrossed Illustrative diagram. Follow device instructions and local clinical protocols.

Common errors that produce inaccurate readings

ErrorPotential effect
Cuff too smallMay falsely elevate the reading.
Arm below heart levelMay falsely elevate the reading.
Arm above heart levelMay falsely lower the reading.
Talking or inadequate restMay raise BP or increase variability.
Legs crossed or feet unsupportedMay raise the reading.
Measuring over clothingCan reduce measurement accuracy.
Single isolated readingMay not represent usual BP; repeat and confirm when appropriate.

ABPM and HBPM

  • ABPM: ambulatory blood pressure monitoring records BP at intervals during normal daily activity and sleep.
  • HBPM: home blood pressure monitoring uses a validated home device and a structured measurement schedule.
  • These methods can help identify white-coat hypertension and masked hypertension.
White-coat hypertension: BP is elevated in the clinical setting but not elevated on out-of-office monitoring.

Masked hypertension: clinic BP is not elevated, but out-of-office BP is elevated.

4. Diagram: Regulation of Blood Pressure

Arterial Blood Pressure Cardiac Output (CO) Heart rate × Stroke volume Systemic Vascular Resistance Arteriolar tone Kidneys and Volume Sodium, water, RAAS Neural and Hormonal Control Sympathetic activity, hormones BP changes with these factors

Simplified physiology diagram. Long-term BP control depends substantially on renal sodium handling and circulating volume; vascular and neural mechanisms also contribute.

5. Types and Causes of Hypertension

A. Primary (essential) hypertension

Persistent hypertension without one identifiable secondary cause. It is multifactorial and may involve genetics, age, dietary sodium, obesity, renal sodium handling, vascular resistance and neurohormonal activity.

B. Secondary hypertension

Hypertension caused or contributed to by an identifiable condition or substance.

CauseExamples or clues
Renal diseaseChronic kidney disease, renal parenchymal disease
Renovascular diseaseRenal artery stenosis
Endocrine conditionsPrimary aldosteronism, pheochromocytoma, thyroid disorders, Cushing syndrome
Obstructive sleep apneaSnoring, witnessed apneas, daytime sleepiness
Coarctation of the aortaMay produce arm–leg BP differences and weak femoral pulses
Medication or substance relatedNSAIDs, corticosteroids, some decongestants, stimulants, certain hormonal medicines and other agents
When to suspect a secondary cause: abrupt onset, unexpectedly severe or resistant hypertension, young age at onset, unexplained low potassium, deterioration in kidney function after specific medicines, or clinical signs of an endocrine disorder.

6. Pathophysiology of Hypertension

Arterial pressure is influenced by cardiac output and systemic vascular resistance.

Approximate relationship:

Mean Arterial Pressure ≈ Cardiac Output × Systemic Vascular Resistance

Hypertension may develop or persist through a combination of:

  1. Increased sympathetic nervous system activity.
  2. Renin–angiotensin–aldosterone system (RAAS) activation.
  3. Renal sodium and water retention, increasing circulating volume.
  4. Increased peripheral vascular resistance.
  5. Vascular stiffness and endothelial dysfunction.
  6. Genetic and environmental influences.

RAAS pathway diagram

Reduced renal perfusion / relevant signals Kidney releases renin Angiotensinogen → Angiotensin I ACE → Angiotensin II Vasoconstriction Increased vascular resistance Aldosterone release Sodium and water retention Can increase blood pressure

Simplified RAAS diagram. Renin release is regulated by multiple signals, and the pathway is more complex than shown.

7. Risk Factors

Non-modifiable factors

  • Increasing age.
  • Family history and genetic susceptibility.
  • Some inherited or congenital conditions.

Modifiable or treatable factors

  • High sodium intake.
  • Overweight and obesity.
  • Physical inactivity.
  • Excessive alcohol consumption.
  • Smoking and tobacco exposure, which increase cardiovascular risk.
  • Sleep deprivation and obstructive sleep apnea.
  • Diabetes, dyslipidemia and kidney disease.
  • Some medicines and substances that elevate BP.

8. Signs and Symptoms

Hypertension is often asymptomatic. Symptoms are not reliable for detecting or excluding it.

Possible symptoms in some patients include:

  • Headache, although headache alone is not diagnostic.
  • Dizziness or nonspecific discomfort.
  • Palpitations or shortness of breath when another condition is present.
  • Visual changes in severe disease or with complications.
Emergency warning signs: severe chest or back pain, acute breathlessness, new weakness or numbness, difficulty speaking, confusion, seizure, sudden visual loss or reduced consciousness require emergency assessment. Do not assume these symptoms are caused by uncomplicated hypertension.

9. Target-Organ Damage

Chronic Hypertension Brain Stroke, vascular injury Heart LVH, CAD, heart failure Kidneys CKD, albuminuria Eyes Hypertensive retinopathy Blood Vessels PAD, aortic disease Long-term vascular stress
OrganPotential complications
HeartLeft ventricular hypertrophy, coronary artery disease, heart failure, atrial fibrillation.
BrainIschemic stroke, hemorrhagic stroke, vascular cognitive impairment.
KidneysChronic kidney disease, albuminuria and progressive loss of renal function.
EyesHypertensive retinopathy and visual impairment in severe disease.
Blood vesselsPeripheral arterial disease and increased risk of aortic disease.

10. Investigations

Investigations assess cardiovascular risk, identify possible secondary causes and look for target-organ damage.

InvestigationPurpose
Repeated standardized BP readingsConfirm persistent elevation and assess control.
Home BP or ABPMIdentify white-coat or masked hypertension and assess usual BP.
Urinalysis and urine albumin-to-creatinine ratioAssess kidney disease and albuminuria.
Serum creatinine and eGFRAssess renal function.
Serum sodium and potassiumAssess electrolyte status and help guide treatment.
Fasting glucose or HbA1cScreen for diabetes and cardiometabolic risk.
Lipid profileAssess cardiovascular risk.
12-lead ECGAssess rhythm and possible left ventricular hypertrophy or ischemia.
Fundoscopy when indicatedAssess hypertensive retinal changes, especially in severe presentations.
Echocardiography when indicatedAssess cardiac structure and function.
Secondary-cause testingSelected tests based on age, symptoms, examination and clinical suspicion.
NORCET tip: Creatinine/eGFR, electrolytes, urine protein or albumin, glucose/HbA1c, lipids and ECG are common elements of the initial evaluation. Not every patient needs every specialized test.

11. Lifestyle and Non-Pharmacological Management

A. Dietary management

  • Reduce sodium intake. The WHO recommends less than 2,000 mg sodium per day for most adults, equivalent to less than 5 g salt per day, unless an individualized clinical plan indicates otherwise.
  • Limit high-salt packaged foods, pickles, papad, salty snacks, processed meats and instant foods.
  • Follow a heart-healthy eating pattern such as DASH: vegetables, fruit, whole grains, legumes, nuts and suitable low-fat dairy, with less saturated fat and added sugar.
  • Increase dietary potassium from food when appropriate. Potassium supplements and potassium-based salt substitutes may be unsafe in kidney disease or with medicines that increase potassium.
  • Limit excessive alcohol consumption; avoiding alcohol may be the safest option for some individuals.

B. Physical activity

  • A common adult goal is at least 150 minutes per week of moderate-intensity aerobic activity, if medically appropriate.
  • Muscle-strengthening activity can be added when suitable.
  • Patients with severe or symptomatic hypertension should receive clinical guidance before strenuous exercise.

C. Other measures

  • Achieve and maintain a healthy weight.
  • Stop smoking and tobacco use to reduce overall cardiovascular risk.
  • Improve sleep and assess for obstructive sleep apnea when suspected.
  • Use stress-management strategies and maintain regular follow-up.
  • Take prescribed medicines consistently; do not stop treatment just because the BP reading improves.
Nursing education: Encourage patients to keep a BP log, bring their monitor to follow-up when possible, and understand the medicine schedule and warning signs. Avoid recommending potassium supplements or salt substitutes without checking for contraindications.

12. Antihypertensive Drugs

Medication selection depends on BP level, age, comorbidities, kidney function, pregnancy status, adverse effects and the applicable guideline. The following are educational summaries, not individual prescriptions.

Drug classExamplesMechanism / common useImportant nursing considerations
ACE inhibitorsEnalapril, lisinoprilReduce angiotensin II formation.Monitor BP, kidney function and potassium. Can cause cough or angioedema. Avoid in pregnancy.
ARBsLosartan, valsartanBlock angiotensin II AT1 receptors.Monitor potassium and kidney function. Avoid in pregnancy. Do not routinely combine with an ACE inhibitor.
Calcium channel blockersAmlodipine; extended-release diltiazem or verapamil in selected casesRelax vascular smooth muscle or reduce heart rate/conduction, depending on class.Amlodipine may cause ankle edema. Verapamil and diltiazem may cause bradycardia or AV block and require suitable patient selection.
Thiazide/thiazide-like diureticsChlorthalidone, indapamide, hydrochlorothiazideIncrease sodium excretion and reduce BP.Monitor sodium, potassium, renal function and volume status; may affect uric acid and glucose.
Beta blockersMetoprolol, bisoprololReduce heart rate and cardiac workload.Useful for selected indications such as certain cardiac conditions; monitor pulse and BP. Do not stop abruptly without medical guidance.
Mineralocorticoid receptor antagonistsSpironolactone, eplerenoneBlock aldosterone effects.Monitor potassium and kidney function; risk of hyperkalemia.
Loop diureticsFurosemidePromote diuresis.Often used for volume overload or specific clinical indications rather than routine uncomplicated hypertension alone. Monitor volume and electrolytes.
Other agentsSelected alpha blockers, central agents and direct vasodilatorsUsed in selected circumstances or resistant hypertension.Adverse effects and monitoring requirements vary by drug.

Common first-line drug classes

For many adults with uncomplicated primary hypertension, commonly used first-line classes include:

  • ACE inhibitor or ARB.
  • Long-acting dihydropyridine calcium channel blocker.
  • Thiazide or thiazide-like diuretic.

Many patients require two medicines, often in a single-pill combination, to achieve control. Selection should be based on the relevant guideline and the patient's clinical profile.

Medication safety:
  • ACE inhibitors and ARBs are contraindicated during pregnancy.
  • ACE inhibitors and ARBs can increase potassium and affect kidney function.
  • Do not combine an ACE inhibitor with an ARB routinely.
  • Beta blockers and non-dihydropyridine calcium channel blockers can slow the heart rate; combination requires careful clinical review.
  • Do not give extra antihypertensive doses or attempt rapid BP reduction without an appropriate clinical order and assessment.

13. Hypertensive Emergency

A hypertensive emergency is severe BP elevation associated with acute target-organ damage. Examples include hypertensive encephalopathy, acute pulmonary edema, acute coronary syndrome, aortic dissection and selected acute kidney or neurological complications.

Warning signs

  • New confusion, seizure or altered consciousness.
  • Focal neurological deficit or suspected stroke.
  • Acute chest pain or suspected aortic dissection.
  • Acute breathlessness or pulmonary edema.
  • Acute visual disturbance with suspected severe hypertensive injury.
  • Evidence of acute kidney injury or other acute organ damage.

Priority nursing management

  1. Recognize and escalate: activate the emergency response or obtain urgent medical review according to local protocol.
  2. Assess ABCs: airway, breathing, circulation, oxygen saturation and level of consciousness.
  3. Repeat BP correctly: use the correct cuff and assess both arms when appropriate, without delaying emergency treatment.
  4. Monitor: continuous or frequent BP, ECG, oxygen saturation and neurological status as indicated.
  5. Establish access and investigations: prepare for ECG, laboratory tests, renal assessment and imaging as ordered.
  6. Administer prescribed therapy: IV antihypertensive treatment may be required in a monitored setting, depending on the cause and organ injury.
  7. Reassess continuously: monitor response, perfusion, urine output and possible adverse effects.
Never lower BP precipitously without a clinical plan. In many hypertensive emergencies, BP is reduced in a controlled manner with monitored IV therapy. The rate and target depend on the specific condition. Aortic dissection, acute stroke and pregnancy-related emergencies have distinct protocols.

Hypertensive emergency versus severe BP elevation without acute organ damage

FeatureHypertensive emergencySevere elevation without acute organ damage
BPOften markedly elevatedMay also be markedly elevated
Acute target-organ damagePresent or strongly suspectedNot identified
ManagementEmergency evaluation, monitored treatment and condition-specific BP reductionPrompt assessment, confirmation of readings, evaluation for causes, appropriate oral therapy or adjustment and close follow-up as clinically indicated

14. Nursing Management

Assessment

  • Measure BP accurately and repeat abnormal readings according to protocol.
  • Assess pulse, respiratory rate, oxygen saturation, pain and neurological status as indicated.
  • Ask about chest pain, dyspnea, headache, visual changes, weakness and medication use.
  • Review adherence, over-the-counter medicines, supplements and substances that may increase BP.
  • Assess for signs of heart failure, stroke, kidney disease and other target-organ damage.

Nursing diagnoses that may be relevant

  • Ineffective health management related to barriers to long-term treatment, when supported by assessment.
  • Deficient knowledge regarding BP monitoring, medicines or lifestyle modification.
  • Risk for decreased cardiac tissue perfusion, depending on the patient's clinical condition.
  • Anxiety related to diagnosis or symptoms, when present.

Planning and interventions

  1. Establish individualized BP goals in collaboration with the treating team.
  2. Provide education on diet, sodium reduction, exercise, sleep and tobacco cessation.
  3. Explain medication purpose, timing, common adverse effects and relevant warning signs.
  4. Encourage a structured home BP log using correct measurement technique.
  5. Arrange follow-up and reinforce the importance of continued treatment.
  6. Escalate severe BP elevations with concerning symptoms or signs of organ damage.

Evaluation

  • BP readings trend toward the agreed individualized target.
  • The patient correctly explains their medication schedule.
  • The patient demonstrates correct home BP measurement.
  • The patient identifies warning signs that require urgent care.
  • Follow-up and investigations are completed as planned.

15. Special Situations

A. Hypertension in pregnancy

  • Pregnancy-related hypertension requires obstetric assessment and pregnancy-specific protocols.
  • Severe hypertension in pregnancy is commonly defined as systolic BP ≥160 mmHg and/or diastolic BP ≥110 mmHg; it requires urgent assessment and treatment.
  • Severe headache, visual symptoms, epigastric or right upper quadrant pain, breathlessness or seizures may indicate a serious pregnancy-related complication.
  • ACE inhibitors and ARBs should not be used during pregnancy.
  • Do not apply ordinary adult non-pregnant treatment targets or emergency protocols without considering pregnancy.
Pregnancy red flag: Severe BP elevation, seizure or symptoms concerning for pre-eclampsia/eclampsia require urgent obstetric emergency management.

B. Orthostatic hypotension during treatment

Assess for dizziness, weakness or syncope when standing, especially in older adults or patients taking diuretics or multiple antihypertensives. If orthostatic measurement is indicated, follow the clinical protocol and implement fall-prevention measures.

C. Resistant hypertension

Resistant hypertension generally refers to BP remaining above target despite an appropriate multidrug regimen, commonly including a diuretic, or BP controlled only with multiple medicines. Before concluding that hypertension is truly resistant, assess measurement technique, adherence, interfering medicines, white-coat effect and secondary causes.

16. Mnemonics and High-Yield Revision

Mnemonic 1: Target organs — “B H K E V”

  • Brain — stroke, encephalopathy.
  • Heart — LVH, CAD, heart failure.
  • Kidneys — CKD, albuminuria.
  • Eyes — retinopathy.
  • Vessels — peripheral arterial and aortic disease.

Mnemonic 2: BP measurement — “REST”

  • Rest quietly for at least 5 minutes.
  • Ensure correct cuff and bare upper arm.
  • Support the back, feet and arm.
  • Take repeat readings and interpret them properly.

Mnemonic 3: Secondary hypertension causes — “RENAL”

  • Renal disease or renal artery stenosis.
  • Endocrine disorders.
  • Night-time breathing disorder (obstructive sleep apnea).
  • Agents and medications that raise BP.
  • Large-vessel disease, such as aortic coarctation.

Last-minute revision table

Question clueKey answer
BP = 120/80 mmHgPulse pressure = 40 mmHg; approximate MAP ≈ 93 mmHg
AHA/ACC 2025 Stage 1130–139 systolic OR 80–89 diastolic
AHA/ACC 2025 Stage 2≥140 systolic OR ≥90 diastolic
NICE hypertension confirmation thresholdClinic ≥140/90 plus confirmatory ABPM/HBPM when appropriate
NICE home/daytime ABPM thresholdAverage ≥135/85 mmHg
Best confirmation methods outside the clinicABPM or HBPM, as appropriate
Major long-term riskHeart, brain, kidney, eye and vascular damage
Common first-line classesACE inhibitor/ARB, long-acting dihydropyridine CCB, thiazide-like diuretic
ACE inhibitor adverse effectCough, hyperkalemia, possible angioedema
ACE inhibitor/ARB in pregnancyAvoid; contraindicated
Hypertensive emergencySevere BP elevation with acute target-organ damage
Severe hypertension in pregnancySBP ≥160 and/or DBP ≥110 mmHg requires urgent assessment
Exam strategy: For a hypertension clinical scenario, identify the actual BP values, check whether the measurement is reliable, look for acute target-organ damage, identify relevant comorbidities and medicines, then select the safest priority action. A very high number alone does not establish a hypertensive emergency.

17. NORCET 12 Practice Test — 25 MCQs

Hypertension: Clinical and Concept-Based MCQs
Question 1 of 25
Time: 30:00

Instructions: Select one best answer. Use Previous and Next to navigate. Each correct answer carries 1 mark. Submit to see your score and explanations.

18. Guideline References and Further Reading

Educational disclaimer: These notes are for nursing education and examination revision. They do not replace local clinical protocols, professional assessment or individualized treatment. Guidelines may differ by country and are periodically updated. For patient care, consult the current applicable guideline and treating clinician.
End of Topic: Hypertension
Revise the BP classification table, proper measurement technique, target-organ complications, antihypertensive drug precautions and the distinction between severe BP elevation and hypertensive emergency. Then complete the 25-question test.

Post a Comment

Welcome to UPNURSING NOTES

Previous Post Next Post